Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute was formed in 1992 for the purposes of funding biomedical research. Specifically genome sequencing efforts. It is the largest charity in the U.K., and receives a majority of its funds from the Wellcome Trust. The Institute is responsible for the completion of the sequencing of approximately 1/3 of the human genome and model genomes of the mouse and zebrafish and more than 90 pathogen genomes. Today, the Wellcome Trust Sanger Institute has been able to attract top scientists and has more than 30 Senior Researchers on staff. The Institute is located in Hinxton, Cambridge, U.K., and spends approximately 650 British Pounds annually to support relevant research by preeminent scientists and labs around the globe. The Institute supports work at the University of Nottingham, MIT, University of Toronto, University of Gothenburg, University of Manchester and other institutions of higher learning research labs.

Address
Hinxton, Cambs, CB10 1SA, UK
E-mail
press.officer@sanger.ac.uk
Fax
+44 (0)1223 494 919
Some content from Wikipedia, licensed under CC BY-SA

Single cells seen in unprecedented detail

Researchers have developed a large-scale sequencing technique called Genome and Transcriptome Sequencing (G&T-seq) that reveals, simultaneously, the unique genome sequence of a single cell and the activity ...

dateApr 27, 2015 in Biotechnology
shares36 comments 0

The biggest expansion of man in prehistory?

DNA sequencing of 36 complete Y chromosomes has uncovered a previously unknown period when the human population expanded rapidly. This population explosion occurred 40 to 50 thousand years ago, between the ...

dateOct 30, 2012 in Evolution
shares0 comments 23

Babies learn mum's unique odour

Researchers show for the first time that a mammal begins to suckle its mother's milk through a learned response built on learning her unique combination of smells. When it is born, the newborn is exposed to the smell of its ...

dateOct 04, 2012 in Plants & Animals
shares0 comments 5